Gold bars to be exempt from tariffs, White House clarifies
DUBLIN - Investment firm Geode Capital Management, LLC has disclosed a 1.01% ownership position in Mural Oncology plc, according to a regulatory filing submitted Tuesday.
The filing, made under the Irish Takeover Panel rules, reveals that Geode holds 175,111 ordinary shares in the oncology-focused company. The position was reported as of Monday, July 14, 2025.
The disclosure also documents a recent transaction in which Geode purchased an additional 350 shares at a price of $2.54 per unit.
The filing was submitted as an opening position disclosure in accordance with Rule 8.3 of the Irish Takeover Panel Act, which requires public disclosure when an entity holds interests in relevant securities representing 1% or more of a company that may be involved in a takeover situation.
Geode Capital indicated in the filing that it has no indemnity arrangements, options, or other agreements relating to the securities. The investment firm also confirmed it is not making disclosures regarding any other party to a potential offer.
The disclosure was made through a Form 8.3 filing to the Regulatory Information Service, as required by Irish takeover regulations.
Mural Oncology is listed on a public exchange, though the specific listing venue was not mentioned in the press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.